NMTR
Closed
9 Meters Biopharma Inc
0.0199
+0.0004 (+2.05%)
Last Update: 26 Sep 2023 16:30:00
Yesterday: 0.0195
Day's Range: 0.0111 - 0.024
Send
sign up or login to leave a comment!
When Written:
1.365
9 Meters Biopharma Inc is a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for rare and unmet medical needs. The company's lead product candidate, NM-002, is a potential treatment for celiac disease, a chronic autoimmune disorder that affects millions of people worldwide.
9 Meters Biopharma also has a pipeline of other product candidates in various stages of development, including a potential treatment for inflammatory bowel disease and a therapy for certain genetic disorders.
The company was founded in 2010 and is headquartered in Raleigh, North Carolina. It went public in 2019 and is listed on the NASDAQ stock exchange under the ticker symbol "NMTR."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
9 Meters Biopharma also has a pipeline of other product candidates in various stages of development, including a potential treatment for inflammatory bowel disease and a therapy for certain genetic disorders.
The company was founded in 2010 and is headquartered in Raleigh, North Carolina. It went public in 2019 and is listed on the NASDAQ stock exchange under the ticker symbol "NMTR."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








